By Nicholas G. Miller
Chemed shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving.
The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months.
The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share.
The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share.
The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
July 29, 2025 17:54 ET (21:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.